Page last updated: 2024-08-17

mannitol and pazopanib

mannitol has been researched along with pazopanib in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Adamson, P; Campochiaro, PA; Gale, DC; Hashida, N; Iwase, T; Krauss, AH; Lima e Silva, R; Oveson, BC; Shen, J	1

Reviews

1 review(s) available for mannitol and pazopanib

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

2 other study(ies) available for mannitol and pazopanib

Article	Year
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
Topical pazopanib blocks VEGF-induced vascular leakage and neovascularization in the mouse retina but is ineffective in the rabbit. Investigative ophthalmology & visual science, 2013, Jan-21, Volume: 54, Issue:1 Topics: Administration, Oral; Administration, Topical; Angiogenesis Inhibitors; Animals; Blood-Retinal Barrier; Capillary Permeability; Female; Fluorophotometry; Indazoles; Intravitreal Injections; Kidney; Lung; Mannitol; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Fluorescence; Pyrimidines; Rabbits; Retinal Neovascularization; Species Specificity; Sulfonamides; Vascular Endothelial Growth Factor A	2013

Article

Year

FDA-approved drug labeling for the study of drug-induced liver injury.

Drug discovery today, 2011, Volume: 16, Issue:15-16

Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011

Topical pazopanib blocks VEGF-induced vascular leakage and neovascularization in the mouse retina but is ineffective in the rabbit.

Investigative ophthalmology & visual science, 2013, Jan-21, Volume: 54, Issue:1

Topics: Administration, Oral; Administration, Topical; Angiogenesis Inhibitors; Animals; Blood-Retinal Barrier; Capillary Permeability; Female; Fluorophotometry; Indazoles; Intravitreal Injections; Kidney; Lung; Mannitol; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Fluorescence; Pyrimidines; Rabbits; Retinal Neovascularization; Species Specificity; Sulfonamides; Vascular Endothelial Growth Factor A

2013